de.mpg.escidoc.pubman.appbase.FacesBean
English
 
Help Guide Disclaimer Contact us Login
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial

MPS-Authors
http://pubman.mpdl.mpg.de/cone/persons/resource/persons81891

Ganoza,  Christian A.
Department of Immunology, Max Planck Institute for Infection Biology, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons82210

Weiner,  January 3rd
Department of Immunology, Max Planck Institute for Infection Biology, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons81969

Kaufmann,  Stefan H. E.
Department of Immunology, Max Planck Institute for Infection Biology, Max Planck Society;

Locator
There are no locators available
Fulltext (public)
There are no public fulltexts available
Supplementary Material (public)
There is no public supplementary material available
Citation

Grode, L., Ganoza, C. A., Brohm, C., Weiner, J. 3., Eisele, B., & Kaufmann, S. H. E. (2013). Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial. Vaccine, 31(9), 1340-1348. doi:10.1016/j.vaccine.2012.12.053.


Cite as: http://hdl.handle.net/11858/00-001M-0000-000E-F4FC-C
Abstract
There is no abstract available